| 摘要 |
The present invention provides use of a morphogen for the manufacture of a medicament for alleviating cancer symptoms, wherein the morphogen inhibits cancer cell growth and is selected from the group consisting of: BMP-9, BMP-11, BMP-14, BMP-15, GDF-8, GDF-9, GDF-11, ADMP and NEURAL. <IMAGE> |
